Document:

Exhibit 10.6

                            NOTE EXTENSION AGREEMENT

                             Dated: ______ __, 2005

     This Note Extension Agreement ("Agreement") is made as of _______ ___, 2005
between Phase III Medical, Inc. (formerly Corniche Group Incorporated) (the
"Company") and _________________________ (the "Lender").

     1. Background. On _____________, 200__ the Lender advanced to the Company
the principal sum of $___________, which loan was evidenced by a promissory note
dated that date (the "Note"). The Note was originally due ____ days after the
date of issuance. Principal payments of $___________ have been made to date, so
that the principal sum of $_________ remains due and owing.

     2. Extension. Notwithstanding the original term of the Note, and
notwithstanding any defaults prior to the date hereof, the Lender agrees that no
further payments shall be due on the Note until ___________ ___, 2005 (the
"Maturity Date"), when all principal and accrued interest shall be due and
payable. Interest on the unpaid principal amount shall be payable monthly in
arrears on the last day of each calendar month.

     3. Other Modifications. Notwithstanding any interest term in the Note,
interest shall accrue from the date hereof through the Maturity Date at a rate
of ____% per annum. All interest has been paid through __________ ___, 2005. The
Lender shall have no further rights to acquire any securities of the Company by
reason of this Note and/or by reason of any default or delay in payment
hereunder. This Note shall not be deemed in default so long as payment is made
on the Maturity Date.

     4. Attachment to Note. The Lender agrees to attach an original of this
Agreement to the original Note.

     5. Representations by Lender. The Lender represents and warrants that it
remains the owner of the Note, and that it has never endorsed, assigned,
transferred, encumbered or otherwise disposed of the Note to any other person or
persons or to any other firm, corporation, or partnership. The Lender agrees not
to transfer the Note prior to the Maturity Date. The Lender agrees to indemnify
the Company against any loss, damage, or liability (including reasonable
attorneys' fees) resulting from or arising out of any breach of the
representations and agreements made by the Lender, including without limitation
any claims, suits, or actions by any person or entity that it is the lawful
holder or owner of the Note.

     IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the
date first written above.

PHASE III MEDICAL, INC.
                                                     ---------------------------
                                                            (Lender)
------------------------                             ---------------------------Exhibit 10.7

                               Catherine M. Vaczy
                            140 East 28th Street #11C
                            New York, New York 10016

Phase III Medical, Inc.
330 South Service Road
Suite 120
Melville, New York  11747
Attention:  Mark Weinreb, President & CEO

August 12, 2005

Dear Mark:

As you know, pursuant to the terms of my employment agreement with Phase III
Medical, Inc. (the "Company") dated April 20, 2005 (the "Employment Agreement"),
I have been accruing my salary as to 50% since April 20, 2005. This letter is
being written to confirm our agreement, as approved by the Board at their
meeting yesterday, that (i) I will cease to accrue salary as of October 1, 2005
and will as of that date begin to receive payment of my salary solely in cash in
accordance with the Company's standard payroll practices, and (ii) I will accept
in payment of my salary accruing during the period that commenced on April 20,
2005 and will end on September 30, 2005, shares (the "Shares") of the common
stock, $.001 par value (the "Common Stock") of the Company. With respect to the
portion of my salary that has accrued from April 20, 2005 through August 12,
2005, the price per share will be $.06, the closing price of the Common Stock
today. For the portion of my salary that will accrue from August 13, 2005
through September 30, 2005, the price per share will be the closing price of the
Common Stock on September 30, 2005.

By signing this agreement, you and I each reaffirm the representations made by
each of us in the Stock Purchase Agreement dated April 20, 2005 and agree that
the Shares are being sold pursuant to the rights and conditions contained
therein, including the right to registration of the Shares.

Please acknowledge your agreement with the foregoing by countersigning this
letter agreement as provided below.

Very truly yours,

/s/ Catherine M. Vaczy
Catherine M. Vaczy

Accepted and agreed:

Phase III Medical, Inc.
By: /s/ Mark Weinreb
     Mark Weinreb, President and CEOExhibit 10.6

                              GULFWEST ENERGY INC.

                             Directors Compensation

Annual  Retainer  and Meeting  Fees.  Effective  June 1, 2005 each  non-employee
Director  will  receive an annual  retainer  of  $10,000  payable  quarterly  in
arrears,  and board meeting  attendance fees in the amount of $2,000 per meeting
if attending in person or $1,000 per meeting if  participating by phone (maximum
annual amount of $8,000).  Committee  members will also receive meeting fees for
committee meetings to the extent that those meetings are held on days other than
scheduled meetings of the entire Board. The Chairman of the Audit Committee will
receive an additional  annual  retainer in the amount of $5,000 and the Chairman
of the  Compensation  Committee will receive an annual retainer in the amount of
$2,500.  Both the Audit Committee and Compensation  Committee  retainers will be
paid  semi-annually.  No Director  who is an  employee  of the  Company  will be
compensated  for service as a member of the Board of Directors or any  committee
of the Board of Directors.

Share Awards.  Effective June 1, 2005 each non-employee Director will receive an
initial grant of $15,000 of restricted  stock (based on the fair market value of
the  stock  on the  date  of  grant)  with a two  year  vesting  schedule.  Upon
re-election,  each non-employee Director will receive an annual grant of $10,000
of  restricted  stock with a one year  vesting  schedule.  Annual  share  awards
received by  non-employee  Directors are in addition to the Annual  Retainer and
Meeting Fees discussed above.

Expenses.  Each  member of the Board of  Directors  will be  reimbursed  for all
direct  expenses  incurred in the  performance  of his/her duties as a Director,
including reasonable travel expenses incurred in attending meetings of the board
or its committees.

<PAGE>

                              GULFWEST ENERGY INC.

                        Summary of Director Compensation
                        --------------------------------

     o    Annual Retainer of $10,000 payable quarterly

     o    Audit Committee Chairman Retainer of $5,000 payable semi-annually

     o    Compensation   Committee   Chairman   Retainer   of   $2,500   payable
          semi-annually

     o    Board  Meeting  Attendance  Fees of $2,000 per  meeting if attended in
          person,   $1,000  if   participating  by  phone  ($8,000  maximum  per
          individual)

     o    Initial grant of $15,000 Restricted Stock with two year vested

     o    Subject to re-election,  annual grant of $10,000 Restricted Stock with
          one year vested

     o    Payment of reasonable  travel  expenses  associated with Board Meeting
          attendanceSonus Networks, Inc.
================================================================================
                                          250 Apollo Drive, Chelmsford, MA 01824

August 9, 2005

Mr. Paul McDermott
18 Nipmuck Drive
Westborough, MA 01581

Dear Paul:

I am  pleased  to  provide  you with the  terms and  conditions  of our offer of
employment to you by Sonus Networks, Inc. (the "Company").

1.   Position.    Your initial position will be VP, Corporate Controller and VP,
Finance,  reporting to Ellen Richstone,  Chief Financial Officer. In addition to
performing  duties and  responsibilities  associated  with the  position  of VP,
Controller  from  time to time the  Company  may  assign  you other  duties  and
responsibilities.

As a full-time employee of the Company, you will be expected to devote your full
business time and energies to the business and affairs of the Company.

2.   Starting  Date/Nature of Relationship.  It is expected that your employment
will start on or within 1 week from August 29, 2005. No provision of this letter
shall be  construed  to create an express or implied  employment  contract for a
specific period of time.  Employment at Sonus  Networks,  Inc. is considered "at
will" and either you or the Company may terminate the employment relationship at
any time and for any reason.

3.   Compensation.

     (a)  Your  initial  salary  will be  annualized  at  $190,000.  You will be
          eligible to participate in the Bonus Program for 2005 (pro-rated) with
          a target of 20% of annual base salary.  Objectives will be agreed upon
          within the first ninety days of your employment.

     (b)  You will be granted  an option to  purchase  150,000  shares of common
          stock under the Company's  Incentive Stock Plan,  subject to the terms
          of the Plan and approval of the Stock Option Committee. Should the
          Company implement a change of control provision for corporate
          officers, this position will be included.

4.   Employment  Eligibility.  In  compliance  with the  Immigration  Reform and
Control Act of 1986,  you are required to establish your identity and employment
eligibility.  Therefore, on your first day of employment you will be required to
fill out an  Employment  Verification  Form and present  documents in accordance
with this form.

5.   Benefits.  You will be  entitled  as an  employee of the Company to receive
such benefits as are generally provided its employees in accordance with Company
policy as in effect from time to time.  Company  benefits  include group health,
life and dental insurance, and liberal holidays, vacation and 401K programs. All
employees  begin  accruing  three (3) weeks of vacation  upon date of hire.  The
Company is committed to providing a healthy work environment for every employee.
Therefore,  we provide a smoke free  environment  and require all  employees  to
comply.

The Company retains the right to change, add or cease any particular benefit.

6.   Confidentiality.  The Company  considers the protection of its confidential
information and  proprietary  materials to be very  important.  Therefore,  as a
condition  of your  employment,  you and the Company  will  become  parties to a
Noncompetition and Confidentiality  Agreement.  Two copies of this agreement are
sent with this offer  letter.  Both  copies  must be signed and  returned to the
Company prior to the first day of employment.

7.   General.

     (a)  This letter will constitute our entire agreement as to your employment
          by  the   Company  and  will   supercede   any  prior   agreements  or
          understandings, whether in writing or oral.

     (b)  This  letter  shall  be  governed  by the law of the  Commonwealth  of
          Massachusetts.

     (c)  Sonus Networks is an equal opportunity employer.

You may accept this offer of employment and the terms and conditions  thereof by
confirming your acceptance by August 17, 2005. Please send your signed letter to
the Company, or via e-mail to Nancy Forte at nforte@sonusnet.com which execution
will evidence your  agreement with the terms and conditions set forth herein and
therein.  You may retain the enclosed copy of this letter for your  records.  We
are  enthusiastic  about you  joining  us, and believe  that our  technical  and
business  goals will provide every  opportunity  for you to achieve you personal
and professional objectives.

Very truly yours,

/s/Colleen Humphrey
-------------------
Colleen Humphrey
Director, Human Resources

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}]]